1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. News
  7. Summary
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-16
43.47 CNY   -1.81%
05/13Fosun Pharma Unit Gets Nod to Start Phase II Study in China of Hematologic Disorder Treatment
MT
05/11Chinese Shares Post Modest Gains; Gotion Jumps 4.5% on Argentina Deal
MT
05/11China’s Pharma Firms Post 67% Jump in Profit in 2021
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Chinese Regulators Accept Fosun Pharma Unit's Registration Application for Hemorrhage Treatment

01/06/2022 | 11:44pm EDT


ę MT Newswires 2022
All news about SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
05/13Fosun Pharma Unit Gets Nod to Start Phase II Study in China of Hematologic Disorder Tre..
MT
05/11Chinese Shares Post Modest Gains; Gotion Jumps 4.5% on Argentina Deal
MT
05/11China’s Pharma Firms Post 67% Jump in Profit in 2021
MT
05/05Hangzhou Calibra Diagnostics Co., Ltd. announced that it has received CNY 220 million i..
CI
04/28SHANGHAI FOSUN PHARMACEUTICAL : Notification letter and request form to non-registered sha..
PU
04/28SHANGHAI FOSUN PHARMACEUTICAL : Form of proxy for holders of h shares for the 2022 first m..
PU
04/28SHANGHAI FOSUN PHARMACEUTICAL : Form of proxy for holders of h shares for the annual gener..
PU
04/28SHANGHAI FOSUN PHARMACEUTICAL : Notice of 2022 first h shareholders class meeting (h share..
PU
04/28SHANGHAI FOSUN PHARMACEUTICAL : Notice of annual general meeting (h shares)
PU
04/28SHANGHAI FOSUN PHARMACEUTICAL : Circular - annual general meeting; proposed issuance of co..
PU
More news
Analyst Recommendations on SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
More recommendations
Financials
Sales 2022 43 494 M 6 455 M 6 455 M
Net income 2022 5 095 M 756 M 756 M
Net Debt 2022 16 460 M 2 443 M 2 443 M
P/E ratio 2022 22,2x
Yield 2022 1,29%
Capitalization 103 B 15 195 M 15 300 M
EV / Sales 2022 2,75x
EV / Sales 2023 2,42x
Nbr of Employees 36 279
Free-Float 58,6%
Chart SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 43,47 CNY
Average target price 55,27 CNY
Spread / Average Target 27,1%
EPS Revisions
Managers and Directors
Yi Fang Wu Chairman & Chief Executive Officer
Yu Qing Chen Co-President
Ke Xin Wang Vice Chairman & Co-President
Dong Ming Li Co-President
De Yong Wen Senior Vice President